NCT05341362

Brief Summary

Supine hypotensive syndrome often occurs following spinal anesthesia for cesarean delivery.In our study we base the regulation and drug administration both on the regular monitor and on a novel monitor which reflects upon the hemodynamic changes. Our aim is to observe whether the outcome of SHS patients with anesthesia management based on hemodynamic figures differs from those based on experience.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

April 17, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 22, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

March 7, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

April 10, 2022

Last Update Submit

March 3, 2023

Conditions

Keywords

supine hypotensive syndromecesarean deliveryspinal anesthesiaCSEA

Outcome Measures

Primary Outcomes (1)

  • Umbilical arterial blood gas PH

    The value is tested immediately after the blood sample is achieved after the infant is born.

    30minutes

Secondary Outcomes (4)

  • Discomfort Score

    1day

  • total vasopressor dosage

    30 minutes

  • Umbilical blood gas lactate

    30minutes

  • Time span

    2 hours

Study Arms (2)

Blank Group

NO INTERVENTION

In this group, the anesthesia management is conducted according to the anesthetists' experience, based on the regular monitor.

LiDCOrapid Group

EXPERIMENTAL

In this group, the anesthesia management is conducted based on both the regular monitor and the hemodynamic figures on the LiDCOrapid.

Procedure: LiDCOrapid

Interventions

LiDCOrapidPROCEDURE

According to the illustration of the patient's hemodynamic figures shown on the LiDCOrapid monitor, we decide on the timing of the vasopressor administration. This group aims to maintain the cardiac output within a baseline range.

LiDCOrapid Group

Eligibility Criteria

Age22 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe disease supine hypotensive syndrome happens among pregnant women in their late pregnancy. Therefore, the participants should be female.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) Physical Status Classification II and had no significant cardiovascular, pulmonary, renal or endocrine disease, without contraindications to CSEA,and could be diagnosed as SHS according to the criteria.

You may not qualify if:

  • Patients undergoing emergency CD, CD under general anesthesia or patients' refusal to participate, or multiple fetations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University

Shenyang, Liaoning, 110000, China

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Undergraduate doctor

Study Record Dates

First Submitted

April 10, 2022

First Posted

April 22, 2022

Study Start

April 17, 2022

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

March 7, 2023

Record last verified: 2023-03

Locations